respiratori
diseas
one
seriou
diseas
complex
affect
beef
cattl
product
usa
ship
fever
common
respiratori
syndrom
cattl
thought
pneumonia
pasteurellosi
analog
condit
hous
suckl
calv
uk
mani
instanc
may
primari
pasteurellosi
howev
enzoot
pneumonia
artifici
rear
dairybr
calv
also
common
uk
microbiolog
appear
much
less
consist
complex
vaccin
avail
consider
period
view
complex
aetiolog
efficaci
equivoc
mani
case
pentaval
inactiv
viral
vaccin
avail
year
compris
bvd
adenoviru
ibr
reoviru
type
found
poorli
immunogen
except
adenoviru
ibr
compon
modifi
live
vaccin
rsv
ibr
also
commerci
avail
field
result
efficaci
former
two
somewhat
equivoc
exampl
one
studi
although
modifi
live
vaccin
produc
immun
respons
protect
experiment
challeng
correspond
reduct
preval
respiratori
diseas
temperatur
sensit
ibr
vaccin
use
time
field
appear
give
good
protect
clinic
entiti
furthermor
claim
vaccin
effect
use
face
outbreak
ibr
one
problem
ibr
vaccin
antibodi
respons
indistinguish
serolog
produc
wild
viru
thu
difficulti
occur
term
diagnosi
particularli
certif
requir
eg
export
purpos
new
quadrival
vaccin
contain
inactiv
antigen
rsv
bovi
dispar
develop
uk
test
last
five
year
appear
given
good
protect
diseas
vaccin
compon
associ
aetiolog
diseas
howev
clear
diseas
still
occur
due
agent
cover
vaccin
sinc
give
complet
protect
inclus
pasteurella
haemolytica
type
would
use
improv
vaccin
state
pasteurella
consid
major
organ
associ
ship
fever
unfortun
doubt
efficaci
pasteurella
bacterin
cattl
although
appear
effect
sheep
work
usa
suggest
immunogen
cytotoxin
p
haemolytica
may
provid
effect
antigen
cattl
vaccin
avail
usa
prevent
bvd
none
current
licens
uk
good
publish
efficaci
data
vaccin
limit
futur
date
commerci
vaccin
produc
littl
precis
knowledg
relev
aetiolog
agent
virul
mechan
import
host
defenc
mechan
consequ
basic
research
requir
area
appropri
vaccin
develop
recombin
technolog
potenti
potent
tool
develop
safe
effect
subunit
vaccin
see
howev
may
time
vaccin
replac
exist
vaccin
due
mainli
rel
simplic
often
low
product
cost
latter
problem
regard
commerci
develop
cattl
pneumonia
vaccin
lie
size
potenti
market
whilst
usa
vaccin
market
quit
larg
approxim
million
much
smaller
canada
million
europ
exampl
total
uk
market
estim
million
includ
lungworm
vaccin
therefor
may
great
commerci
incent
pharmaceut
compani
develop
product
cours
might
argu
market
relat
vaccin
efficaci
therefor
good
vaccin
produc
potenti
market
much
greater
